CCN3/Nephroblastoma Overexpressed Is a Functional Mediator of Prostate Cancer Bone Metastasis That Is Associated with Poor Patient Prognosis.

[1]  S. Komarova,et al.  Exosomal Release of L-Plastin by Breast Cancer Cells Facilitates Metastatic Bone Osteolysis1 , 2018, Translational oncology.

[2]  T. H. van der Kwast,et al.  The Terry Fox Research Institute Canadian Prostate Cancer Biomarker Network: an analysis of a pan-Canadian multi-center cohort for biomarker validation , 2018, BMC Urology.

[3]  Y. Tsai,et al.  CCN3 promotes epithelial-mesenchymal transition in prostate cancer via FAK/Akt/HIF-1α-induced twist expression , 2017, Oncotarget.

[4]  Ximing J. Yang,et al.  Polycomb-Mediated Disruption of an Androgen Receptor Feedback Loop Drives Castration-Resistant Prostate Cancer. , 2017, Cancer research.

[5]  W. Jiang,et al.  Emerging role of CCN family proteins in tumorigenesis and cancer metastasis (Review) , 2015, International journal of molecular medicine.

[6]  F. Saad,et al.  Managing bone metastases and reducing skeletal related events in prostate cancer , 2014, Nature Reviews Clinical Oncology.

[7]  Howard I. Scher,et al.  High-risk prostate cancer—classification and therapy , 2014, Nature Reviews Clinical Oncology.

[8]  Chih-Hsin Tang,et al.  Prostate cancer-derived CCN3 induces M2 macrophage infiltration and contributes to angiogenesis in prostate cancer microenvironment , 2014, Oncotarget.

[9]  T. Kuzel,et al.  CCN3/NOV gene expression in human prostate cancer is directly suppressed by the androgen receptor , 2014, Oncogene.

[10]  Chih-Hsin Tang,et al.  CCN3 promotes prostate cancer bone metastasis by modulating the tumor-bone microenvironment through RANKL-dependent pathway. , 2013, Carcinogenesis.

[11]  Tien-Huang Lin,et al.  CCN3 increases cell motility and ICAM-1 expression in prostate cancer cells. , 2012, Carcinogenesis.

[12]  P. Siegel,et al.  CCN3 modulates bone turnover and is a novel regulator of skeletal metastasis , 2012, Journal of Cell Communication and Signaling.

[13]  Véronique Ouellet,et al.  CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone. , 2011, The American journal of pathology.

[14]  F. Pépin,et al.  ADAM10 Releases a Soluble Form of the GPNMB/Osteoactivin Extracellular Domain with Angiogenic Properties , 2010, PloS one.

[15]  B. Perbal.  Alternative splicing of CCN mRNAs …. it has been upon us , 2009, Journal of Cell Communication and Signaling.

[16]  M. Ikeda,et al.  Inhibitory effect of CT domain of CCN3/NOV on proliferation and differentiation of osteogenic mesenchymal stem cells, Kusa-A1. , 2008, Biochemical and biophysical research communications.

[17]  F. Pépin,et al.  Osteoactivin Promotes Breast Cancer Metastasis to Bone , 2007, Molecular Cancer Research.

[18]  A. Ori,et al.  Antiproliferative activity of CCN3: Involvement of the C‐terminal module and post‐translational regulation , 2007, Journal of cellular biochemistry.

[19]  R. Vessella,et al.  Xenograft Models of Human Prostate Cancer , 2007 .

[20]  M. Silva,et al.  Spiculated periosteal response induced by intraosseous injection of 22Rv1 prostate cancer cells resembles subset of bone metastases in prostate cancer patients , 2005, The Prostate.

[21]  G. Coetzee,et al.  Prostate specific antigen gene regulation by androgen receptor , 2004, Journal of cellular biochemistry.

[22]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[23]  C. Naus,et al.  Proposal for a unified CCN nomenclature , 2003, Molecular pathology : MP.

[24]  R. Vessella,et al.  Establishment and characterization of osseous prostate cancer models: Intra‐tibial injection of human prostate cancer cells , 2002, The Prostate.

[25]  R. Ball,et al.  Differential expression of the ccn3 (nov) proto-oncogene in human prostate cell lines and tissues , 2001, Molecular pathology : MP.

[26]  L. Chung,et al.  LNCaP progression model of human prostate cancer: Androgen‐independence and osseous metastasis , 2000, The Prostate.

[27]  B. Perbal.  Nuclear localisation of NOVH protein: a potential role for NOV in the regulation of gene expression. , 1999, Molecular pathology : MP.

[28]  C. Kao,et al.  Establishing human prostate cancer cell xenografts in bone: Induction of osteoblastic reaction by prostate‐specific antigen‐producing tumors in athymic and SCID/bg mice using LNCaP and lineage‐derived metastatic sublines , 1998, International journal of cancer.

[29]  L. Chung,et al.  Androgen-independent cancer progression and bone metastasis in the LNCaP model of human prostate cancer. , 1994, Cancer research.